PMCTPharmaCountry
    Startseite
TL

Tarek Leil

Executive Director
568
25
7

Aktuelle Unternehmen

DS
Daiichi Sankyo (United States)
Executive Director
Seit Jan. 2021

Ausbildung

  • University of California Los Angeles
    Abschluss PhD
    Studienrichtung Pharmacology
    Startdatum 01/1998
    Enddatum 01/2004

Berufserfahrung

Bristol Myers Squibb

Executive Director

Bristol Myers Squibb •

01/2011 – 01/2021 •

Quantitative Clinical Pharmacology

PG

Pfizer Global Research and Development •

01/2010 – 01/2011 •

Clinical Pharmacology

Bristol Myers Squibb

Sr Research Investigator

Bristol Myers Squibb •

01/2007 – 01/2010 •

Modeling & Simulation